Literature DB >> 12537781

Molecular basis of implantation.

A Pellicer1, F Dominguez, J Remohi, C Simón.   

Abstract

The process of embryonic implantation needs coordinated development and communication between the blastocyst and the maternal endometrium. Considerable advances in the understanding of the cell biology of the human embryo and maternal endometrium have been achieved separately. However, the communication between them, and the reciprocal effects on each other, constitute a complicated and yet unsolved question in reproductive medicine that must be further investigated. A paracrine dialogue between the embryo, endometrium and the corpus luteum is known to occur in other species such as rodents and primates. The aim of this work is to present updated information on the embryonic regulation of endometrial epithelial molecules such as adhesion molecules, anti-adhesion molecules, cytoskeletal proteins, chemokines and leptin during the apposition and adhesion phases of human implantation.

Entities:  

Mesh:

Year:  2002        PMID: 12537781     DOI: 10.1016/s1472-6483(11)60216-2

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  3 in total

1.  Marijuana-derived cannabinoids inhibit uterine endometrial stromal cell decidualization and compromise trophoblast-endometrium cross-talk.

Authors:  Naveen K Neradugomma; Kaitlyn Drafton; Gil G Mor; Qingcheng Mao
Journal:  Reprod Toxicol       Date:  2019-05-30       Impact factor: 3.143

2.  Mir-661: A key Factor in Embryo-Maternal dialog With Potential Clinical Application to Predict Implantation Outcome?

Authors:  Antonio Cano; Raul Gomez
Journal:  EBioMedicine       Date:  2015-09-28       Impact factor: 8.143

3.  Expression of E-Cadherin in Pig-Tailed Monkey (Macaca nemestrina) Endometrium after Controlled Ovarian Hyperstimulation.

Authors:  Nurhuda Sahar; R Muharam; Andhea Debby Pradhita; Rosalina Thuffi; Wa Ode Zulhulaifah; Ponco Birowo
Journal:  Biomed Res Int       Date:  2021-02-23       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.